FDA Approved: MIRALAX — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

The FDA approved a supplemental application for MIRALAX (polyethylene glycol 3350) by Bayer HealthCare LLC to update the labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• MIRALAX (POLYETHYLENE GLYCOL 3350)

Snippet

SUPPL AP for MIRALAX (POLYETHYLENE GLYCOL 3350)